Plasma cell leukemia (PCL) is a rare disease that may ... lenalidomide and transplant-based regimens will probably improve treatment outcome. There is insufficient information to support ...

CAR T cell immunotherapy, which uses a patient's own modified immune cells to find and destroy cancer cells, can produce ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

Introduction The global blood products market is experiencing steady growth due to several key drivers. A major factor is the increasing number ...

Oshawa Generals captain and Toronto Maple Leaf draft pick Ben Danford has given his fair share of blood in battles on the ice but his most important fight is for those in the community in need of ...

Labcorp LH recently announced the expansion of its precision oncology portfolio, which includes new test offerings for solid ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk of developing ...

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Plasma therapy is one of several different experimental longevity procedures that involve blood transfers, including platelet ...

B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...